ArticleFrontiers in physiology2026
Temporal dynamics of glomerular and microvascular remodeling in high-altitude renal injury: a structure-function analysis in rats.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The temporal dynamics of renal acclimatization during the sub-acute transition to high altitude remain poorly defined. Specifically, the relationship between structural integrity and functional adaptation under sustained hypobaric hypoxia is unclear. This study aims to characterize the time-dependent trajectories of renal remodeling and identify the critical biological window for potential intervention. Methods: Male Sprague-Dawley (SD) rats were randomized to a normobaric normoxia control group or a simulated hypobaric hypoxia group (5,000 m, PO2: 11.3 kPa) for 3, 7, 14, and 28 days (n=6/group). Renal filtration function was assessed via serum creatinine (CRE) and cystatin C (CysC), while tubular injury and systemic inflammation were evaluated using neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18). Structural alterations were quantified through hematoxylin and eosin (H&E) and Periodic Acid-Schiff (PAS) staining, with peritubular capillary (PTC) density assessed via immunohistochemistry. The temporal associations and exploratory biomarker discrimination were analyzed using restricted cubic spline (RCS) regression, Spearman correlation, and receiver operating characteristic (ROC) analyses. Results: Despite stable gross kidney weight and length throughout the exposure, histological analysis revealed progressive microscopic injury. PTC density exhibited a continuous, time-dependent decline that was significantly inversely correlated with tubular injury scores and medullary congestion. Notably, glomerular morphometry exhibited a distinct biphasic response: an initial significant reduction in glomerular diameter at Day 3, followed by subsequent enlargement peaking at Day 14. Temporally, serum biomarkers showed heterogeneous and exploratory trajectories, whereas histological injury remained more persistent. CysC and CRE showed overall temporal variation, but Tukey-adjusted Conclusion: Hypobaric hypoxia induces a distinct state of structure-function uncoupling, characterized by persistent microvascular rarefaction that antedates measurable systemic functional decline. The first week of exposure represents a biologically active phase of vascular remodeling and tubular stress. These findings suggest that relying solely on functional markers may underestimate the severity of sub-clinical renal injury in hypoxic environments, highlighting the potential value of integrating structural biomarkers for more accurate risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.